CDE

U.S. Bank Receives $55 Million in New Markets Tax Credit Allocation

Retrieved on: 
Friday, September 29, 2023

U.S. Bancorp Impact Finance, a subsidiary of U.S. Bank, and its community development entity (CDE) – USBCDE, LLC – received $55 million of New Markets Tax Credit (NMTC) allocation from the U.S. Department of Treasury.

Key Points: 
  • U.S. Bancorp Impact Finance, a subsidiary of U.S. Bank, and its community development entity (CDE) – USBCDE, LLC – received $55 million of New Markets Tax Credit (NMTC) allocation from the U.S. Department of Treasury.
  • The allocation is part of the federal government’s $5 billion NMTC program, which helps economically distressed communities attract private investment capital.
  • USBCDE, LLC has now been awarded more than $1 billion in total allocations, one of only three CDEs to do so.
  • It is one of 102 CDEs to receive a share of the NMTC allocation authority package announced by the Treasury’s Community Development Financial Institutions Fund (CDFI Fund).

Clearinghouse CDFI Secures $60 Million in New Market Tax Credits from the United States Department of Treasury--Will Create Jobs and Services in Distressed Communities

Retrieved on: 
Friday, September 29, 2023

LAKE FOREST, Calif., Sept. 29, 2023 /PRNewswire-PRWeb/ -- Clearinghouse Community Development Financial Institution (Clearinghouse CDFI) announced today that it has been awarded a $60 million New Markets Tax Credit (NMTC) allocation from the United States Department of Treasury, CDFI Fund. Clearinghouse CDFI will use the tax credits to finance community investments in low-income and urban areas in Alaska, Arizona, California, Colorado, Hawaii, Idaho, Minnesota, Montana, Nevada, New Mexico, North Dakota, Oklahoma, Oregon, South Dakota, Utah, Washington, Wisconsin, and Wyoming.

Key Points: 
  • LAKE FOREST, Calif., Sept. 29, 2023 /PRNewswire-PRWeb/ -- Clearinghouse Community Development Financial Institution (Clearinghouse CDFI) announced today that it has been awarded a $60 million New Markets Tax Credit (NMTC) allocation from the United States Department of Treasury, CDFI Fund.
  • "We are grateful to the CDFI Fund and Department of Treasury for this meaningful allocation which will create jobs and drive resources to many distressed communities," said Douglas J. Bystry, President and CEO of Clearinghouse CDFI.
  • "Tax credits are an important tool in community and economic development, making large projects with grand impact possible."
  • Since inception, Clearinghouse CDFI has deployed over $629 million of Federal and State NMTC allocation to 89 unique projects nationwide.

Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China

Retrieved on: 
Monday, September 18, 2023

SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) granted Breakthrough Therapy Designation for efgartigimod alfa injection (subcutaneous injection) (efgartigimod SC) for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

Key Points: 
  • SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) granted Breakthrough Therapy Designation for efgartigimod alfa injection (subcutaneous injection) (efgartigimod SC) for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
  • The Breakthrough Therapy Designation for efgartigimod SC was supported by data from both global and Chinese patients enrolled in the ADHERE study.
  • “We have seen how efgartigimod SC can meaningfully improve and stabilize disease symptoms in these patients.
  • Existing treatment options are quite limited, and problematic given the general reliance on long-term steroid or chronic immunoglobulin therapy.

CDFI Awards Rural Development Partners $50 Million in NMTC Authority

Retrieved on: 
Friday, September 22, 2023

FOREST CITY, Iowa, Sept. 22, 2023 /PRNewswire/ -- Rural Development Partners (RDP) was awarded $50 million in New Markets Tax Credit (NMTC) authority from the U.S. Treasury's CDFI Fund .

Key Points: 
  • FOREST CITY, Iowa, Sept. 22, 2023 /PRNewswire/ -- Rural Development Partners (RDP) was awarded $50 million in New Markets Tax Credit (NMTC) authority from the U.S. Treasury's CDFI Fund .
  • This is RDP's twelfth NMTC award since the company's inception in 2004, totaling $751.7 million.
  • The New Markets Tax Credit program incentivizes community development and economic growth by attracting private capital to low-income, underserved communities.
  • Rural Development Partners is a Community Development Entity (CDE) with a national service area, eligible to apply for an annual allocation of Federal NMTCs.

Coeur Announces Initial Production From Rochester Expansion and Substantial Completion of Construction

Retrieved on: 
Monday, September 18, 2023

Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today announced the achievement of several critical milestones at its major Rochester expansion project in Nevada, including the production of the first silver and gold ounces.

Key Points: 
  • Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today announced the achievement of several critical milestones at its major Rochester expansion project in Nevada, including the production of the first silver and gold ounces.
  • Following a ramp-up period expected to last into early 2024, Rochester is expected to drive a step-change in the Company’s overall production levels, cost profile, and cash flow.
  • First Silver and Gold Produced – Metal production from the new Stage VI leach pad and Merill-Crowe process plant leach began mid-month with initial doré expected to be poured today.
  • Construction of Crushing Circuit Substantially Complete – With the primary gyratory crusher now installed, construction of the new three-stage crushing circuit is now substantially complete.

H2U Achieves Unprecedented Performance and Durability with Non-Iridium Catalysts

Retrieved on: 
Tuesday, September 19, 2023

CHATSWORTH, Calif., Sept. 19, 2023 /PRNewswire/ -- H2U Technologies, a next-generation electrolyzer developer, has performed durability tests on new, lower-cost, iridium-free catalyst materials that demonstrate a projected lifetime of 25,000 hours. This groundbreaking durability milestone represents a significant breakthrough and addresses supply chain bottlenecks for sustainable hydrogen production with Proton Exchange Membrane (PEM) electrolyzers.

Key Points: 
  • This groundbreaking durability milestone represents a significant breakthrough and addresses supply chain bottlenecks for sustainable hydrogen production with Proton Exchange Membrane (PEM) electrolyzers.
  • For perspective, the best iridium-free catalysts known to date offer lifetimes of approximately 1,000 to 1,400 hours.
  • H2U catalysts are projected to last at least six years for targeted applications, such as in PEM electrolyzers paired with curtailed renewables.
  • Our CDE team found promising catalysts and developed a unique process to integrate the materials into membrane electrode assemblies to optimize activity and durability.

Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, September 12, 2023

SAN DIEGO and TAICANG, China, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today reported financial results for the six months ended June 30, 2023 and provided a business update.

Key Points: 
  • SAN DIEGO and TAICANG, China, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today reported financial results for the six months ended June 30, 2023 and provided a business update.
  • “We also reported positive long-term data from the Phase 2 maintenance period in ulcerative colitis with our other late-stage asset – icanbelimod.
  • There were no new safety signals and icanbelimod continued to be well-tolerated, consistent with observed induction period safety data.
  • Published in July 2023 the pre-clinical data characterizing rademikibart in Nature’s Scientific Reports.

Coder 2.0 Lets Developers Create, Access and Collaborate from Anywhere

Retrieved on: 
Wednesday, September 13, 2023

Coder simplifies cloud-based development so that developers can focus on their work," said Elliot Graebert, Skydio's Director of Engineering, Infrastructure.

Key Points: 
  • Coder simplifies cloud-based development so that developers can focus on their work," said Elliot Graebert, Skydio's Director of Engineering, Infrastructure.
  • The benefits are so compelling that a third of Skydio's developers are using Coder on a daily basis."
  • New features in Coder 2.0 include:
    Envbuilder for Dev Containers, an open source project by Coder based on the Microsoft Dev Containers specification.
  • Today, Coder and its founders remain driven by the goal of keeping developers in flow by providing limitless computational power and storage, allowing developers to build applications and collaborate quickly and easily, in real time.

Coeur Announces Positive Exploration Results at Kensington; Large-Scale Drilling Program Ramps Up at Silvertip

Retrieved on: 
Tuesday, September 12, 2023

The Company has completed approximately 40% of its planned 2023 exploration drilling program and roughly 55% of its planned 2023 underground mine development program, which has led to approximately 2,500 feet of additional mineralized strike length.

Key Points: 
  • The Company has completed approximately 40% of its planned 2023 exploration drilling program and roughly 55% of its planned 2023 underground mine development program, which has led to approximately 2,500 feet of additional mineralized strike length.
  • At Silvertip, resource expansion efforts and step-out drilling commenced in July with four rigs now in operation as part of a sustained 18-month, resource expansion exploration program.
  • This led to the planning of an aggressive four-year exploration program aimed at extending the life of mine beyond 2030.
  • “Recent drill results at Kensington clearly demonstrate that this mineralizing system continues,” said Aoife McGrath, Senior Vice President of Exploration.

CDE Lightband Plugs in ATX Visium SBB to Enhance Services to Commercial Customers

Retrieved on: 
Wednesday, September 6, 2023

In addition to customer retention and loyalty, a chief benefit of the Visium SBB is its ability to reduce maintenance costs and trouble calls at the senior facilities.

Key Points: 
  • In addition to customer retention and loyalty, a chief benefit of the Visium SBB is its ability to reduce maintenance costs and trouble calls at the senior facilities.
  • Before installation of the ATX SBB, power interruptions or other failures would require maintenance personnel to rescan residents’ televisions, a process that took about 15 minutes per television.
  • The Visium SBB’s capability to configure a channel lineup from a USB key in less than a minute makes it very efficient to deploy and maintain.
  • “Kudos to the AMT team for working so closely with CDE Lightband to solve this critical service issue and protect their commercial service business.”
    For more information about the Visium SBB or any of ATX’s media distribution solutions, please visit www.atx.com .